Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) (coVIHd-19)
Evaluation of the Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)
Sponsor: Tourcoing Hospital
Listed as NCT04581746, this NA trial focuses on Covid19 and Virus-HIV and remains ongoing. Sponsored by Tourcoing Hospital, it has been updated 7 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2021 — Jun 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Tourcoing Hospital
For direct contact, visit the study record on ClinicalTrials.gov .